BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10855379)

  • 1. [Paroxetine withdrawal syndrome].
    Belloeuf L; Le Jeunne C; Hugues FC
    Ann Med Interne (Paris); 2000 Apr; 151 Suppl A():A52-3. PubMed ID: 10855379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Severe withdrawal symptoms with fever during paroxetine tapering off].
    Peeters FP; Zandbergen J
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1429-31. PubMed ID: 10422558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin reuptake inhibitor withdrawal.
    Coupland NJ; Bell CJ; Potokar JP
    J Clin Psychopharmacol; 1996 Oct; 16(5):356-62. PubMed ID: 8889907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal.
    Price JS; Waller PC; Wood SM; MacKay AV
    Br J Clin Pharmacol; 1996 Dec; 42(6):757-63. PubMed ID: 8971432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuing paroxetine: a personal account.
    Shoenberger D
    Psychother Psychosom; 2002; 71(4):237-8. PubMed ID: 12097790
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitor. Discontinuation syndrome.
    Finfgeld DL
    J Psychosoc Nurs Ment Health Serv; 2002 Dec; 40(12):14-8. PubMed ID: 12491870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [SSRI discontinuation syndrome: incidence and differences on three groups of patients treated with paroxetine].
    Rusconi AC; Carlone C; Muscillo M; Coccanari de' Fornari MA; Podda L; Piccione M
    Riv Psichiatr; 2009; 44(3):169-75. PubMed ID: 20066803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Withdrawal syndrome caused by selective serotonin reuptake inhibitors: apropos of a case].
    Bryois C; Rubin C; Zbinden JD; Baumann P
    Praxis (Bern 1994); 1998 Mar; 87(10):345-8. PubMed ID: 9545842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Withdrawal symptoms in connection with the use of selective serotonin reuptake inhibitors (SSRI)].
    Gram LF
    Ugeskr Laeger; 1998 Dec; 160(50):7291-3. PubMed ID: 9859737
    [No Abstract]   [Full Text] [Related]  

  • 11. More cases of paroxetine withdrawal syndrome.
    Pacheco L; Malo P; Aragues E; Etxebeste M
    Br J Psychiatry; 1996 Sep; 169(3):384. PubMed ID: 8879736
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse events after the abrupt discontinuation of paroxetine.
    Dominguez RA; Goodnick PJ
    Pharmacotherapy; 1995; 15(6):778-80. PubMed ID: 8602387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severe withdrawal symptoms with fever upon stopping paroxetine].
    Bakker A
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1795; author reply 1795-6. PubMed ID: 10494333
    [No Abstract]   [Full Text] [Related]  

  • 14. [Withdrawal syndrome after the use of serotonin reuptake inhibitors].
    Fagan M
    Tidsskr Nor Laegeforen; 2000 Mar; 120(8):913-4. PubMed ID: 10795494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Severe withdrawal symptoms with fever upon stopping paroxetine].
    Vergouwen AC; Kuipers T
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1794-5; author reply 1795-6. PubMed ID: 10494332
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a home-based Nightcap evaluation during drug administration and withdrawal.
    Silvestri R; Pace-Schott EF; Gersh T; Stickgold R; Salzman C; Hobson JA
    J Clin Psychiatry; 2001 Aug; 62(8):642-52. PubMed ID: 11561938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute dystonia following paroxetine withdrawal].
    Cabo-López I; García-Bermejo P; González-Roiz C; Durán-Martínez P; García-Ruiz PJ
    Rev Neurol; 2008 Feb 16-29; 46(4):253-4. PubMed ID: 18327750
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of disequilibrium and nausea in the SRI discontinuation syndrome.
    Schechter JO
    J Clin Psychiatry; 1998 Aug; 59(8):431-2. PubMed ID: 9721826
    [No Abstract]   [Full Text] [Related]  

  • 19. Palinopsia and paroxetine withdrawal.
    Terao T
    J Clin Psychiatry; 2002 Apr; 63(4):368. PubMed ID: 12000213
    [No Abstract]   [Full Text] [Related]  

  • 20. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
    Zajecka J; Tracy KA; Mitchell S
    J Clin Psychiatry; 1997 Jul; 58(7):291-7. PubMed ID: 9269249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.